Shirley Chen is a Global Health Equity Advisory Board Member at AstraZeneca. She possess expertise in cross functional team leadership, product development, business strategy, r&d, pharmaceutical industry and 15 more skills. She is proficient in Chinese and Spanish. Colleagues describe her as "I can certainly recommend Shirley as an experienced Director with amazing drive, and great collaboration skills. Shirley has consistently contributed to the development of a successful Established Products Commercial Unit by: (1) conciliating different regions market dynamics and development needs into a unified Cross-EM vision, (2) having a constant, close and motivating follow-up with Regional EP leads to achieve results, (3) by enhancing the P&L management capabilities of the team."